|Articles|October 26, 2016
Q2 Solutions Collaborates with Illumina
Q2 Solutions, a global clinical trials laboratory services organization, has come to an agreement with Illumina, a global genomics provider.
Advertisement
Q2 Solutions, a global clinical trials laboratory services organization, has come to an agreement with Illumina, a global genomics provider. Under this agreement, the companies will establish a framework for developing next-generation sequencing-based (NGS) CDx assays.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating Trials into Routine Care
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
4
FDA Outlines New Superiority Standard for Future CAR-T Approvals
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
